Chapter 7: Copyright and COVID
Restricted access

The rise of the COVID-19 pandemic revived a focus of scholars and policy makers on the issue of patents and access to medicines (and vaccines). But the COVID-19 pandemic displayed as well how other intellectual property rights, including copyright and trade secrets, may also complicate public health measures. This chapter documents many instances where non-patent forms of intellectual property created barriers to the global scale-up of access to vaccines, treatments, and the ability to contain the COVID-19 virus. It concludes by explaining some of the existing flexibilities in the multilateral intellectual property system that may be used to respond to these problems.

You are not authenticated to view the full text of this chapter or article.

Access options

Get access to the full article by using one of the access options below.

Other access options

Redeem Token

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institutional Access

Personal login

Log in with your Elgar Online account

Login with your Elgar account